Comparison between Dr.Lal PathLabs IPO and Shree Pushkar Chemicals IPO.
Dr.Lal PathLabs IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Shree Pushkar Chemicals IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Dr.Lal PathLabs IPO is up to ₹631.91 Cr whereas the issue size of the Shree Pushkar Chemicals IPO is up to ₹70.00 Cr. The final issue price of Dr.Lal PathLabs IPO is ₹550.00 per share and of Shree Pushkar Chemicals IPO is ₹65.00 per share.
| Dr.Lal PathLabs IPO | Shree Pushkar Chemicals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹540.00 per share | ₹61.00 per share |
| Issue Price (Upper) | ₹550.00 per share | ₹65.00 per share |
| Issue Price (Final) | ₹550.00 per share | ₹65.00 per share |
| Discount (Retail) | ₹15.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 20 shares | 200 shares |
| Fresh Issue Size | 0 shares | 87,42,611 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹56.83 Cr |
| OFS Issue Size | 1,16,00,000 shares | 20,26,589 shares |
| OFS Issue Size (Amount) | up to ₹631.91 Cr | up to ₹13.17 Cr |
| Issue Size Total | 1,16,00,000 shares | 1,07,69,200 shares |
| Issue Size Total (Amount) | up to ₹631.91 Cr | up to ₹70.00 Cr |
Dr.Lal PathLabs IPO opens on Dec 08, 2015, while Shree Pushkar Chemicals IPO opens on Aug 25, 2015. The closing date of Dr.Lal PathLabs IPO and Shree Pushkar Chemicals IPO is Dec 10, 2015, and Aug 27, 2015, respectively.
| Dr.Lal PathLabs IPO | Shree Pushkar Chemicals IPO | |
|---|---|---|
| Anchor Bid Date | Dec 07, 2015 | |
| Issue Open | Dec 08, 2015 | Aug 25, 2015 |
| Issue Close | Dec 10, 2015 | Aug 27, 2015 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Dec 23, 2015 | Sep 10, 2015 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Dr.Lal PathLabs IPO P/E ratio is , as compared to Shree Pushkar Chemicals IPO P/E ratio of .
| Dr.Lal PathLabs IPO | Shree Pushkar Chemicals IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 63.67 | |||||
| Promoter Shareholding (Post-Issue) | 58.7 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹4545.46 Cr. | ₹196.43 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 27.85% |
In the Dr.Lal PathLabs IPO Retail Individual Investors (RII) are offered 40,60,000 shares while in Shree Pushkar Chemicals IPO retail investors are offered 40,60,000 shares. Qualified Institutional Buyers (QIB) are offered 23,20,000 shares in Dr.Lal PathLabs IPO and 53,84,600 shares in Shree Pushkar Chemicals IPO.
| Dr.Lal PathLabs IPO | Shree Pushkar Chemicals IPO | |
|---|---|---|
| Anchor Investor Reservation | 34,80,000 shares | |
| Market Maker Reservation | ||
| QIB | 23,20,000 shares | 53,84,600 shares |
| NII | 17,40,000 shares | 16,15,380 shares |
| RII | 40,60,000 shares | 37,69,220 shares |
| Employee | ||
| Others | ||
| Total | 1,16,00,000 shares | 1,07,69,200 shares |
Dr.Lal PathLabs IPO subscribed 33.41x in total, whereas Shree Pushkar Chemicals IPO subscribed 1.34x.
| Dr.Lal PathLabs IPO | Shree Pushkar Chemicals IPO | |
|---|---|---|
| QIB (times) | 63.56x | 0.97x |
| NII (times) | 61.28x | 2.09x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 4.24x | 1.54x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 33.41x | 1.34x |
